Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VENLAFAXINE Cause Insurance issue? 11 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Insurance issue have been filed in association with VENLAFAXINE (Venlafaxine Hydrochloride). This represents 0.0% of all adverse event reports for VENLAFAXINE.

11
Reports of Insurance issue with VENLAFAXINE
0.0%
of all VENLAFAXINE reports
1
Deaths
4
Hospitalizations

How Dangerous Is Insurance issue From VENLAFAXINE?

Of the 11 reports, 1 (9.1%) resulted in death, 4 (36.4%) required hospitalization, and 1 (9.1%) were considered life-threatening.

Is Insurance issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VENLAFAXINE. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does VENLAFAXINE Cause?

Drug ineffective (5,408) Toxicity to various agents (3,917) Nausea (2,989) Completed suicide (2,929) Headache (2,668) Dizziness (2,426) Off label use (2,310) Overdose (2,220) Intentional overdose (2,187) Fatigue (2,153)

What Other Drugs Cause Insurance issue?

CERTOLIZUMAB PEGOL (1,210) HUMAN IMMUNOGLOBULIN G (1,090) LISDEXAMFETAMINE DIMESYLATE (590) RIFAXIMIN (577) LENALIDOMIDE (376) ARIPIPRAZOLE (345) HUMAN C1-ESTERASE INHIBITOR (295) HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (253) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (227) ETANERCEPT (220)

Which VENLAFAXINE Alternatives Have Lower Insurance issue Risk?

VENLAFAXINE vs VENTAVIS VENLAFAXINE vs VENTOLIN VENLAFAXINE vs VENTOLIN HFA VENLAFAXINE vs VERAPAMIL VENLAFAXINE vs VERICIGUAT

Related Pages

VENLAFAXINE Full Profile All Insurance issue Reports All Drugs Causing Insurance issue VENLAFAXINE Demographics